American College of Clinical Pharmacy
      Search      Cart

Click an article title to view the article online, or click the Download button to view the PDF newsletter.

NIH Releases Major Update to the COVID-19 Treatment Guidelines
Dec 01, 2022
SAP Posttest Deadlines Extended
Nov 16, 2022
From the Desk of the ACCP Past President...
Oct 20, 2022
NIH Releases New Statement on Omicron Subvariants and Anti-SARS-CoV-2 Monoclonal Antibodies
Oct 19, 2022
Creating an Inclusive Culture at ACCP: Membership Votes to Approve Amendment to Bylaws
Oct 17, 2022
NIH Publishes New Version of COVID-19 Treatment Guidelines
Sep 26, 2022
From the Desk of the ACCP President
Sep 06, 2022
Pharmacotherapy Publishes Consensus Recommendations for Use of Maintenance Immunosuppression in Solid Organ Transplantation
Aug 30, 2022
Information about an Upcoming Special Vote on a Proposed Amendment to the ACCP Bylaws
Aug 26, 2022
NIH Publishes COVID-19 Treatment Guidelines Update on Anti-SARS-CoV-2 Monoclonal Antibodies
Aug 19, 2022
INFORMATION FOR ACCP MEMBERS: Monkeypox Vaccination/Treatment and Call for Clinician Input
Aug 19, 2022
Major Update to COVID-19 Treatment Guidelines Released
Aug 09, 2022
Hernandez Selected as Sixth NAM Fellow in Pharmacy
Aug 09, 2022
ACCP Joins Multi-Stakeholder Advocacy Effort to Strengthen Nation’s Public Health Preparedness
Aug 08, 2022
Pfizer Releases DHCP Letter and Updated Fact Sheet to Minimize Paxlovid Wrong Dose Medication Errors
Aug 08, 2022
BPS Extends Deadline for Applications for 2022-2023 PGY2 Pharmacy Residency Research Grants
Aug 08, 2022
Call for Applications: 2023-2024 ACCP Professional Leadership APPE
Aug 01, 2022
GTMRx Provides Information to HHS on Initiative to Strengthen Primary Care
Aug 01, 2022
From the Desk of the ACCP President
Jul 05, 2022
Pharmacotherapy’s Impact Factor Increased to 6.251!
Jun 28, 2022
ACCP Responds to CDC and ACIP on COVID-19 Vaccine Recommendation in Children 6 Months and Up
Jun 21, 2022
New Version of the COVID-19 Treatment Guidelines Released
Jun 01, 2022
NIH Panel Updates COVID-19 Treatment Guidelines
May 16, 2022
ACCP Urges Passage of Legislation Covering Clinical Pharmacist Consultations
May 12, 2022
NIH Panel Issues April 29 Update to COVID-19 Treatment Guidelines
Apr 29, 2022
ACCP Authors Issue Brief on Comprehensive Medication Management for Substance Use Disorder in the Addiction Recovery Medical Home
Apr 26, 2022
ACCP Joins Pharmacy-Wide Outreach to White House COVID-19 Response Coordinator
Apr 20, 2022
COVID-19 Treatment Guidelines Remove Sotrovimab Recommendation
Apr 08, 2022
Sotrovimab Recommendation Revised in COVID-19 Treatment Guidelines
Apr 01, 2022
ACCP Joins 28 State & National Pharmacy Organizations Urging Congress to Fully Fund the COVID-19 Uninsured Program
Mar 31, 2022
NIH Panel Releases New COVID-19 Treatment Guidelines Updates
Mar 25, 2022
ACCP Joins Pharmacy Colleagues Across the Profession to Support the Equitable Community Access to Pharmacist Services Act (ECAPS)
Mar 24, 2022
‘Better Health — Now’ Campaign Aims to Help Patients Benefit from More Community-Based Primary Care
Mar 24, 2022
FDA to Hold April 6 Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters
Mar 21, 2022
ACCP Supports Pharmacy-Wide Effort to Advance PIE Act
Mar 18, 2022
Pharmacist Groups Call on Biden Administration to Remove Limits on Prescribing COVID Treatments
Mar 09, 2022
NIH Panel Releases New Statement on Bebtelovimab for the Treatment of High-Risk Patients With Mild to Moderate COVID-19
Mar 02, 2022
NIH Panel Releases Update to COVID-19 Treatment Guidelines
Feb 25, 2022
FDA Authorizes Revisions to Evusheld Dosing
Feb 25, 2022
American Epilepsy Society Issues Updated Information on the Risks of Valproate Use in Women of Childbearing Potential
Feb 09, 2022
NIH Panel Releases New Statement on Therapies for High-Risk, Non-Hospitalized Patients
Jan 20, 2022
NIH Panel Releases New Statements on Tixagevimab Plus Cilgavimab and Anticoagulation in Hospitalized Patients with COVID-19
Jan 07, 2022
NIH Panel Releases New Statements on Use of Oral COVID-19 Antivirals
Dec 30, 2021
NIH Panel Releases New Statement on Use of Monoclonal Antibodies or Remdesivir versus Omicron Variant Prioritization for Treatment or Prevention in the Face of Logistical/Supply Constraints
Dec 24, 2021
From the Desk of the ACCP President
Dec 21, 2020